New Notice of U.S. Patent Allowance Granted to Axim® Biotechnologies for Suppository Formulations Comprising Cannabinoids

New Notice of U.S. Patent Allowance Granted to Axim® Biotechnologies for Suppository Formulations Comprising Cannabinoids

NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new Notice of Allowance for a patent (Application No. 16/122,079) on a suppository composition comprising cannabinoids. READ MORE: http://www.globenewswire.com/news-release/2019/11/21/1950855/0/en/New-Notice-of-U-S-Patent-Allowance-Granted-to-Axim-Biotechnologies-for-Suppository-Formulations-Comprising-Cannabinoids.html The post New Notice of U.S. Patent Allowance Granted to Axim® Biotechnologies for Suppository Formulations Comprising Cannabinoids appeared first on Cannabis Daily.

Excerpt only …
READ MORE BELOW
Source : New feed
Link to original : New Notice of U.S. Patent Allowance Granted to Axim® Biotechnologies for Suppository Formulations Comprising Cannabinoids
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.